Stephen F. Betz insider trades
Open-market stock purchases and sales by Stephen F. Betz, Chief Scientific Officer at Crinetics Pharmaceuticals, Inc, from SEC Form 4 filings since Oct 21, 2021.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc | Sold (not open market) | $5M |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc | Sold (not open market) | $6.8M |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc | Sold (not open market) | $7.5M |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc | Sold (not open market) | $5.6M |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc | Sold (not open market) | $3.4M |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc | Sold (not open market) | $3.7M |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc | Sold (not open market) | $5.9M |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc | Sold (not open market) | $927K |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc | Sold (not open market) | $5M |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc | Sold (not open market) | $7.2M |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc | Sold (not open market) | $3.6M |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc | Sold (not open market) | $3.1M |
| Sep 1, 2026 | CRNX Crinetics Pharmaceuticals, Inc | Sold (not open market) | $1.9M |
| Mar 16, 2026 | CRNX Crinetics Pharmaceuticals, Inc | Sold | $236K |
| Mar 16, 2026 | CRNX Crinetics Pharmaceuticals, Inc | Sold | $160K |
| Feb 23, 2026 | CRNX Crinetics Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 23, 2026 | CRNX Crinetics Pharmaceuticals, Inc | Bought (not open market) | — |
| Dec 26, 2025 | CRNX Crinetics Pharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- CRNX Crinetics Pharmaceuticals, Inc: 53 sales, last Sep 1, 2026